Hemophilia is a rare, inherited bleeding disorder in which the blood does not clot normally due to a deficiency in essential ...

The World Federation of Hemophilia (WFH) and WFH USA, together with Sanofi, through its philanthropic organization Foundation ...

Efanesoctocog alfa, prescribed weekly and exorbitantly priced, is found not cost-effective in treating severe hemophilia A.

Many people in Kenya may be living with an undiagnosed rare bleeding disorder known as hemophilia, which may put them at risk ...

Sobi® (STO: SOBI) together with the World Federation of Hemophilia (WFH) and Sanofi, through its philanthropic organisation Foundation S, announced the signing of a contract providing support to the ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi (marstacimab) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35kg with ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...

The World Federation of Hemophilia (WFH) is a non-profit organization dedicated to improving and sustaining care for people with inherited bleeding disorders around the world. At the WFH, national ...